Vertex Pharmaceuticals

Ownership: Public

Industries: Healthcare & Pharmaceuticals - Biotechnology

Revenue: over $1B

Employees: over 10K

Web Address: www.vrtx.com

Phone: (617) 341-6100

Fax:

Email:

Business Description:
Vertex Pharmaceuticals Incorporated is engaged in the business of discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company operates in pharmaceuticals segment. Its business is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. Its marketed medicines are ORKAMBI and KALYDECO, which are approved to treat patients with CF having specific mutations in their CF transmembrane conductance regulator (CFTR) gene. It has multiple development programs in the field of CF, including VX-661, VX-371, and VX-152 and VX-440. It is engaged in various other research and mid- and early-stage development programs, such as programs in the areas of onc... (Source: SEC reports)

Recently Updated profiles at this company 301 Contacts at this company